Skip to content

Watch our latest webinar on "beside to podium" delivered by Prof James Hull!

Treatable Traits

Center of Excellence Treatable Traits
  • About
  • Who we are
  • Our Research
    • Severe refractory asthma
    • Difficult-to-treat asthma
    • Moderate asthma
    • Asthma in pregnancy
    • Australian Mepolizumab Registry for Chronic Rhinosinusitis with Nasal Polyps
    • TTOCS Study
    • Centre Publications
  • Research Impact
    • Annual Report 2022
    • Annual Report 2023
    • Oral Corticosteroid Use in Asthma: Impact Case Study
  • News
  • Events
  • Training Resources & Development
    • ILO/VCD Toolkit
    • Severe Asthma Toolkit
    • Asthma in Pregnancy Toolkit
    • White Paper: OUTCOMES AND METHODOLOGY FOR TREATABLE TRAITS BASED RESEARCH
  • Resources
    • Latest Resources
    • Infographics
    • Webinars
    • Useful Resources
  • Community
  • Contact
Center of Excellence Treatable Traits
  • About
  • Who we are
  • Our Research
    • Severe refractory asthma
    • Difficult-to-treat asthma
    • Moderate asthma
    • Asthma in pregnancy
    • Australian Mepolizumab Registry for Chronic Rhinosinusitis with Nasal Polyps
    • TTOCS Study
    • Centre Publications
  • Research Impact
    • Annual Report 2022
    • Annual Report 2023
    • Oral Corticosteroid Use in Asthma: Impact Case Study
  • News
  • Events
  • Training Resources & Development
    • ILO/VCD Toolkit
    • Severe Asthma Toolkit
    • Asthma in Pregnancy Toolkit
    • White Paper: OUTCOMES AND METHODOLOGY FOR TREATABLE TRAITS BASED RESEARCH
  • Resources
    • Latest Resources
    • Infographics
    • Webinars
    • Useful Resources
  • Community
  • Contact

Acknowledgement of Country
The National Centre of Asthma Treatable Traits acknowledges Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn, and work.

© 2025 Treatable Traits. All rights reservered.

WordPress Login Website Design by bounce